Press release
Pneumococcal Vaccines Market is booming 2019 | Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc
Healthcare facilities are looking forward to expand their facilities with advanced technologies to create innovative and cost-effective solutions to address barriers to universal vaccinationFor instance, in April 2016, Glaxo Smith Kline (GSK) and Vodafone collaborated to provide smartphones with an app to various healthcare facilities in northern Mozambique, Africa for a period of one year. The program received funds from GAVI and United States Agency for International Development (USAID) under mVacciNation pilot program. The app enables these healthcare facilities to report regularly on vaccine stock levels and refrigerator temperatures, thereby improving critical supply chain and cold chain management. Furthermore, it helps health workers to register patients, view their vaccination histories, and also allows to send reminders to registered patients for their next vaccination.
Request Sample of This Report: www.coherentmarketinsights.com/insight/request-sample/2295
Increasing collaborations among key players to develop and introduce new pneumococcal vaccines and ongoing clinical trial studies on pneumococcal vaccine are expected to drive growth of the pneumococcal vaccines market. For instance, in April 2018, Merck & Co, Inc. initiated two Phase III studies of PCV-15 (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease.
Furthermore, in February 2017, Astellas Pharma Inc. and Affinivax, Inc. signed an exclusive worldwide license agreement to develop and commercialize a vaccine targeting Streptococcus pneumoniae. This partnership would utilize Affinivax’s proprietary vaccine technology platform – Multiple Antigen Presenting System (MAPS) to develop a novel vaccine.
Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns. Therefore, vendors are focused on joining Advance Market Commitment (AMC), an innovative financing program. Under AMC, international agencies pay a premium above the incremental production cost for initial doses sold to emerging economies in exchange of continuous supply of vaccines from vendors at sustainable prices for long term.
In 2010, Pfizer entered into the AMC program and agreed to supply 300 Mn doses of PCV13 for pneumococcal disease. Subsequently, Pfizer entered into two additional agreements with the AMC expanding its commitment with an additional 440 Mn doses, for a total commitment of 740 Mn doses of PCV13 vaccine until 2025.
Get PDF Brochure of Research Report - https://www.coherentmarketinsights.com/insight/request-pdf/2295
Moreover, in 2015, Pfizer reduced prices of four new dose vial presentations of PCV13, which was expected to be introduced under the AMC program in 2016. The prices were reduced by 20% per-dose i.e., from US$ 3.30 per dose to US$ 3.10 per dose.
Key players operating in the pneumococcal vaccines market include, Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccines Market is booming 2019 | Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc here
News-ID: 1837498 • Views: …
More Releases from CMI Research

Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune …
Eosinophilic Esophagitis (EoE) is a chronic inflammatory condition of the esophagus. It is characterized by the accumulation of a type of white blood cells called eosinophils in the lining of the esophagus. EoE can cause a range of symptoms, including difficulty swallowing, food impaction, chest pain, and heartburn.
Steroids are the primary treatment option for EoE. They help control inflammation and reduce the number of eosinophils in the esophagus. Topical steroids…

A complete guide to Adoptive Cell Therapy Market 2023: growing demand for person …
Adoptive cell therapy (ACT) is a form of immunotherapy that involves the genetic modification of T cells to enhance their cancer-fighting capabilities. This treatment has shown promising results in the treatment of several types of cancer and is expected to become a major player in the oncology market in the coming years.
The global adoptive cell therapy market size was valued at USD 1.12 billion in 2021 and is projected to…

A complete guide to the TCV Vaccines Market 2023: market size, growth trends, ke …
Conjugate vaccine (Vi-TT) consists of Vi antigen that is coupled to a carrier protein. In this vaccine, polysaccharide is attached to a more complex protein. In infants, these cells can effectively develop immune protection against pathogens. Polysaccharides are weaker by itself, however, by binding to a protein carrier, polysaccharides can enter into important parts of the immune system with ease and can get more easily noticed by the immunity system…

A complete guide to Corporate Wellness Market 2023: Market size, growth trends, …
The corporate wellness market has been gaining popularity over the years as more companies recognize the importance of keeping their employees healthy and productive. Corporate wellness programs are designed to improve the overall health and well-being of employees by providing them with resources and support to manage their physical and mental health.
The corporate wellness market is expected to grow significantly from 2023-2030. According to a report by Coherent Market Insights,…
More Releases for AMC
Global AMC Filters for Semiconductor Market Analysis (2024-2029)
On July 23, 2024, LPI (LP Information) released the report titled "Global AMC Filters for Semiconductor Market Growth (Status and Outlook) 2024-2030." This report provides a comprehensive analysis of the global AMC Filters for Semiconductor landscape, with a focus on key trends related to product segmentation, company establishment, revenue and market share, recent developments, and merger and acquisition activities. Additionally, the report delves into the strategies of global leading companies,…
Lokekey Productions Clarifies Misleading Claims Regarding AMC Theaters Collabora …
Chicago, IL - Lokekey Productions [http://www.lokekey.com], a prominent independent film production company based in Chicago, is addressing recent rumors suggesting that AMC Theaters declined a partnership with the company. These claims, which have been circulating online, are entirely unfounded, and Lokekey Productions is setting the record straight to avoid any misunderstandings.
Image: https://www.abnewswire.com/uploads/c0244cf96ada5329e532a7f6c1ad74d4.png
The Origins and Impact of the Rumors
Over the past 24 hours, Lokekey Productions has received numerous inquiries from fans,…
Investigation announced for Long-Term Investors in shares of AMC Entertainment H …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at AMC Entertainment Holdings Inc.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain AMC Entertainment Holdings Inc (directors breached their fiduciary duties and caused damage to the company…
AMC Entertainment Holdings Inc (NYSE: AMC) Investor Notice: Lawsuit filed agains …
Investors in shares of AMC Entertainment Holdings Inc (NYSE: AMC) filed a lawsuit against certain directors of AMC Entertainment Holdings Inc over alleged wrongdoing in connection with the proposed stock increase.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) and currently hold any of those: AMC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
In August 2022 , the…
Dale play premieres at AMC theatre in NY
With the presence of its directors, actors and cinema lovers, NYC Latin Media film company held the premiere gala of its most recent film Dale Play, by the Dominican director Walmy De La Cruz at the Lowes AMC facilities in Manhattan.
The film, produced by Raquel Ureña and Steve Sanchez, and was shot entirely between Connecticut and New York.
"Dale Play" stars the Dominican actor Manny Gomez and the puertorican actress…
AMC Entertainment Holdings Inc (NYSE: AMC) Investor Alert: Investigation over po …
An investigation on behalf of current long-term investors in shares of AMC Entertainment Holdings Inc (NYSE: AMC) was announced over potential breaches of fiduciary duties by certain officers and directors at AMC Entertainment Holdings Inc (NYSE: AMC.
Investors who purchased shares of AMC Entertainment Holdings Inc (NYSE: AMC) and currently hold any of those AMC Entertainment Holdings Inc (NYSE: AMC shares have certain options and should contact the Shareholders Foundation at…